reference/33663160

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33663160

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1471-2407
issueIdentifier	1
pageRange	547-
publicationName	BMC Cancer
startingPage	547
bibliographicCitation	Li W, Li DM, Chen K, Chen Z, Zong Y, Yin H, Xu ZK, Zhu Y, Gong FR, Tao M. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study. BMC Cancer. 2012 Nov 23;12():547. PMID: 23173703; PMCID: PMC3574000.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46cac0388c9c7b20a554cfa01e050ee3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e2f32ba4669f823005b42b057d4342b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5651248565e7af37c1be13b89ff2caeb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_569a3edd5ab745ec77c4fd929a259929 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95834c2d32c9fccad255e6dcbaae49f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0959b6d1c6e90d85307fc9b1f5778ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b3a794f0207619e575d5afb3bc9c0ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20febd3b0efb0a9215a784006b8203b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9038e3da1d1b8d4e849d8aa00518bd75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aab00deda37eae405b28f2d1d15468dc
date	2012-11-23^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/23173703 https://doi.org/10.1186/1471-2407-12-547 https://pubmed.ncbi.nlm.nih.gov/PMC3574000
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020 https://portal.issn.org/resource/ISSN/1471-2407
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study
discusses	http://id.nlm.nih.gov/mesh/M0003285 http://id.nlm.nih.gov/mesh/M0000763 http://id.nlm.nih.gov/mesh/M0014578 http://id.nlm.nih.gov/mesh/M0007520 http://id.nlm.nih.gov/mesh/M0016671 http://id.nlm.nih.gov/mesh/M0506640
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009363Q000037 http://id.nlm.nih.gov/mesh/D000509Q000235 http://id.nlm.nih.gov/mesh/D008114Q000628 http://id.nlm.nih.gov/mesh/D054648Q000037 http://id.nlm.nih.gov/mesh/D015316Q000379 http://id.nlm.nih.gov/mesh/D010735Q000235 http://id.nlm.nih.gov/mesh/D006528Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004742 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D054648Q000502 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D011401 http://id.nlm.nih.gov/mesh/D017209Q000502 http://id.nlm.nih.gov/mesh/D004791Q000494 http://id.nlm.nih.gov/mesh/D008114Q000201 http://id.nlm.nih.gov/mesh/D002193Q000494 http://id.nlm.nih.gov/mesh/D002453Q000502 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D009363Q000502 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D006528Q000201
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.3.16 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f45a1981a993269f904dc188447f840b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.2.3 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20224990 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a2b5aea7fa54ea9b959dc534d39bf4b1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_06b6236473a3dcb335fc5bd7246d7e92

Showing number of triples: 1 to 64 of 64.